Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · IEX Real-Time Price · USD
1.490
+0.010 (0.68%)
Jul 22, 2024, 10:27 AM EDT - Market open
Milestone Pharmaceuticals Employees
Milestone Pharmaceuticals had 47 employees as of December 31, 2023. The number of employees increased by 8 or 20.51% compared to the previous year.
Employees
47
Change (1Y)
8
Growth (1Y)
20.51%
Revenue / Employee
n/a
Profits / Employee
-$1,172,106
Market Cap
80.03M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
PetMed Express | 287 |
Marinus Pharmaceuticals | 166 |
Affimed | 76 |
Boundless Bio | 72 |
Leap Therapeutics | 54 |
Ikena Oncology | 43 |
Forian | 37 |
Oncolytics Biotech | 29 |
MIST News
- 5 weeks ago - Milestone Pharmaceuticals to Host KOL Event for Investors “Learnings from the Field: Expert Perspectives on PSVT in the Community Setting” on June 20, 2024 - GlobeNewsWire
- 7 weeks ago - Milestone® Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Milestone Pharmaceuticals Announces FDA Acceptance of New Drug Application for CARDAMYST™ - GlobeNewsWire
- 2 months ago - Milestone Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Regulatory and Corporate Update - GlobeNewsWire
- 3 months ago - Milestone® Pharmaceuticals to Present Data on Etripamil at the Preventative Cardiovascular Nursing Symposium - GlobeNewsWire
- 3 months ago - Milestone® Pharmaceuticals Announces Etripamil Data Demonstrating Patients' Ability to Self-Manage Recurring PSVT, Presented at The American College of Cardiology Annual Meeting - GlobeNewsWire
- 4 months ago - Milestone® Pharmaceuticals to Present Data on Etripamil at the American College of Cardiology and European Heart Rhythm Association Annual Conferences - GlobeNewsWire
- 4 months ago - Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Regulatory and Corporate Update - GlobeNewsWire